Additionally, lower counts of CD4+ T helper cells limit the activation of effector immune cells, causing inadequate immune response signaling and a tumor microenvironment unresponsive to immune efforts aimed at attacking the tumor [19]. This evidence concerns the gene CD4 and neoplasm.